Company Filing History:
Years Active: 2011-2012
Title: Min Michael He: Innovator in Pharmaceutical Dosage Forms
Introduction
Min Michael He is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative dosage forms. With a total of 2 patents, his work focuses on enhancing the efficacy and reliability of pharmaceutical formulations.
Latest Patents
Min Michael He's latest patents include "Methods for making pharmaceutical dosage forms containing active cushioning components" and "Extended release formulation and method of treating adrenergic dysregulation." The first patent describes novel methods for creating dosage forms that can be compressed while maintaining uniform composition and robustness, which also exhibit reduced friability. Additionally, it relates to methods for producing fast-disintegrating dosage forms. The second patent outlines a composition and method for treating adrenergic dysregulation, utilizing a2-adrenergic receptor agonists combined with a hydrophilic matrix and a metal alkyl sulfate release-retardant. This formulation aims to provide sustained release of the agonist, ensuring optimal plasma concentration levels.
Career Highlights
Throughout his career, Min Michael He has worked with reputable organizations such as Shionogi Pharma, Inc. and the University System of Maryland. His experience in these institutions has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Min Michael He has collaborated with notable colleagues, including Henry Joseph Horacek and Moise A Khayrallah. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Min Michael He stands out as an influential inventor in the pharmaceutical industry, with a focus on improving dosage forms for better patient outcomes. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical sciences.